Below are the three companies in the Biotechnology industry with the highest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.
Biogen Idec (NASDAQ:BIIB) is highest with sales per share of $25.08. Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.
In the past 52 weeks, shares of Biogen Idec have traded between a low of $134.00 and a high of $248.95 and are now at $238.95, which is 78% above that low price. The 200-day and 50-day moving averages have moved 1.13% higher and 0.60% higher over the past week, respectively.
Following is Amgen (NASDAQ:AMGN) with sales per share of $23.26.
Finishing up the top three is United Therapeutics (NASDAQ:UTHR), with sales per share of $20.05.